Global AI for Pharma and Biotech Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by AI for Pharma and Biotech Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global AI for Pharma and Biotech Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Deep Learning
  • 1.4.3 Big Data
  • 1.4.4 Image Detection
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global AI for Pharma and Biotech Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Research Center
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): AI for Pharma and Biotech Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the AI for Pharma and Biotech Industry
    • 1.6.1.1 AI for Pharma and Biotech Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and AI for Pharma and Biotech Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for AI for Pharma and Biotech Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 AI for Pharma and Biotech Market Perspective (2015-2026)
• 2.2 AI for Pharma and Biotech Growth Trends by Regions
  • 2.2.1 AI for Pharma and Biotech Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 AI for Pharma and Biotech Historic Market Share by Regions (2015-2020)
  • 2.2.3 AI for Pharma and Biotech Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 AI for Pharma and Biotech Market Growth Strategy
  • 2.3.6 Primary Interviews with Key AI for Pharma and Biotech Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top AI for Pharma and Biotech Players by Market Size
  • 3.1.1 Global Top AI for Pharma and Biotech Players by Revenue (2015-2020)
  • 3.1.2 Global AI for Pharma and Biotech Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global AI for Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global AI for Pharma and Biotech Market Concentration Ratio
  • 3.2.1 Global AI for Pharma and Biotech Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by AI for Pharma and Biotech Revenue in 2019
• 3.3 AI for Pharma and Biotech Key Players Head office and Area Served
• 3.4 Key Players AI for Pharma and Biotech Product Solution and Service
• 3.5 Date of Enter into AI for Pharma and Biotech Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global AI for Pharma and Biotech Historic Market Size by Type (2015-2020)
• 4.2 Global AI for Pharma and Biotech Forecasted Market Size by Type (2021-2026)

5 AI for Pharma and Biotech Breakdown Data by Application (2015-2026)

• 5.1 Global AI for Pharma and Biotech Market Size by Application (2015-2020)
• 5.2 Global AI for Pharma and Biotech Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America AI for Pharma and Biotech Market Size (2015-2020)
• 6.2 AI for Pharma and Biotech Key Players in North America (2019-2020)
• 6.3 North America AI for Pharma and Biotech Market Size by Type (2015-2020)
• 6.4 North America AI for Pharma and Biotech Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe AI for Pharma and Biotech Market Size (2015-2020)
• 7.2 AI for Pharma and Biotech Key Players in Europe (2019-2020)
• 7.3 Europe AI for Pharma and Biotech Market Size by Type (2015-2020)
• 7.4 Europe AI for Pharma and Biotech Market Size by Application (2015-2020)

8 China

• 8.1 China AI for Pharma and Biotech Market Size (2015-2020)
• 8.2 AI for Pharma and Biotech Key Players in China (2019-2020)
• 8.3 China AI for Pharma and Biotech Market Size by Type (2015-2020)
• 8.4 China AI for Pharma and Biotech Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan AI for Pharma and Biotech Market Size (2015-2020)
• 9.2 AI for Pharma and Biotech Key Players in Japan (2019-2020)
• 9.3 Japan AI for Pharma and Biotech Market Size by Type (2015-2020)
• 9.4 Japan AI for Pharma and Biotech Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia AI for Pharma and Biotech Market Size (2015-2020)
• 10.2 AI for Pharma and Biotech Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia AI for Pharma and Biotech Market Size by Type (2015-2020)
• 10.4 Southeast Asia AI for Pharma and Biotech Market Size by Application (2015-2020)

11 India

• 11.1 India AI for Pharma and Biotech Market Size (2015-2020)
• 11.2 AI for Pharma and Biotech Key Players in India (2019-2020)
• 11.3 India AI for Pharma and Biotech Market Size by Type (2015-2020)
• 11.4 India AI for Pharma and Biotech Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America AI for Pharma and Biotech Market Size (2015-2020)
• 12.2 AI for Pharma and Biotech Key Players in Central & South America (2019-2020)
• 12.3 Central & South America AI for Pharma and Biotech Market Size by Type (2015-2020)
• 12.4 Central & South America AI for Pharma and Biotech Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 CureMetrix
  • 13.1.1 CureMetrix Company Details
  • 13.1.2 CureMetrix Business Overview and Its Total Revenue
  • 13.1.3 CureMetrix AI for Pharma and Biotech Introduction
  • 13.1.4 CureMetrix Revenue in AI for Pharma and Biotech Business (2015-2020))
  • 13.1.5 CureMetrix Recent Development
• 13.2 Enlitic
  • 13.2.1 Enlitic Company Details
  • 13.2.2 Enlitic Business Overview and Its Total Revenue
  • 13.2.3 Enlitic AI for Pharma and Biotech Introduction
  • 13.2.4 Enlitic Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.2.5 Enlitic Recent Development
• 13.3 VoxelCloud
  • 13.3.1 VoxelCloud Company Details
  • 13.3.2 VoxelCloud Business Overview and Its Total Revenue
  • 13.3.3 VoxelCloud AI for Pharma and Biotech Introduction
  • 13.3.4 VoxelCloud Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.3.5 VoxelCloud Recent Development
• 13.4 Insilico Medicine
  • 13.4.1 Insilico Medicine Company Details
  • 13.4.2 Insilico Medicine Business Overview and Its Total Revenue
  • 13.4.3 Insilico Medicine AI for Pharma and Biotech Introduction
  • 13.4.4 Insilico Medicine Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.4.5 Insilico Medicine Recent Development
• 13.5 Oncora Medical
  • 13.5.1 Oncora Medical Company Details
  • 13.5.2 Oncora Medical Business Overview and Its Total Revenue
  • 13.5.3 Oncora Medical AI for Pharma and Biotech Introduction
  • 13.5.4 Oncora Medical Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.5.5 Oncora Medical Recent Development
• 13.6 Atomwise
  • 13.6.1 Atomwise Company Details
  • 13.6.2 Atomwise Business Overview and Its Total Revenue
  • 13.6.3 Atomwise AI for Pharma and Biotech Introduction
  • 13.6.4 Atomwise Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.6.5 Atomwise Recent Development
• 13.7 TwoXAR
  • 13.7.1 TwoXAR Company Details
  • 13.7.2 TwoXAR Business Overview and Its Total Revenue
  • 13.7.3 TwoXAR AI for Pharma and Biotech Introduction
  • 13.7.4 TwoXAR Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.7.5 TwoXAR Recent Development
• 13.8 Berg Health
  • 13.8.1 Berg Health Company Details
  • 13.8.2 Berg Health Business Overview and Its Total Revenue
  • 13.8.3 Berg Health AI for Pharma and Biotech Introduction
  • 13.8.4 Berg Health Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.8.5 Berg Health Recent Development
• 13.9 CloudMedX
  • 13.9.1 CloudMedX Company Details
  • 13.9.2 CloudMedX Business Overview and Its Total Revenue
  • 13.9.3 CloudMedX AI for Pharma and Biotech Introduction
  • 13.9.4 CloudMedX Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.9.5 CloudMedX Recent Development
• 13.10 Deep Genomics
  • 13.10.1 Deep Genomics Company Details
  • 13.10.2 Deep Genomics Business Overview and Its Total Revenue
  • 13.10.3 Deep Genomics AI for Pharma and Biotech Introduction
  • 13.10.4 Deep Genomics Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 13.10.5 Deep Genomics Recent Development
• 13.11 Johnson & Johnson
  • 10.11.1 Johnson & Johnson Company Details
  • 10.11.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 10.11.3 Johnson & Johnson AI for Pharma and Biotech Introduction
  • 10.11.4 Johnson & Johnson Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 10.11.5 Johnson & Johnson Recent Development
• 13.12 Roche
  • 10.12.1 Roche Company Details
  • 10.12.2 Roche Business Overview and Its Total Revenue
  • 10.12.3 Roche AI for Pharma and Biotech Introduction
  • 10.12.4 Roche Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 10.12.5 Roche Recent Development
• 13.13 Pfizer
  • 10.13.1 Pfizer Company Details
  • 10.13.2 Pfizer Business Overview and Its Total Revenue
  • 10.13.3 Pfizer AI for Pharma and Biotech Introduction
  • 10.13.4 Pfizer Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 10.13.5 Pfizer Recent Development
• 13.14 Novartis
  • 10.14.1 Novartis Company Details
  • 10.14.2 Novartis Business Overview and Its Total Revenue
  • 10.14.3 Novartis AI for Pharma and Biotech Introduction
  • 10.14.4 Novartis Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 10.14.5 Novartis Recent Development
• 13.15 Bayer
  • 10.15.1 Bayer Company Details
  • 10.15.2 Bayer Business Overview and Its Total Revenue
  • 10.15.3 Bayer AI for Pharma and Biotech Introduction
  • 10.15.4 Bayer Revenue in AI for Pharma and Biotech Business (2015-2020)
  • 10.15.5 Bayer Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer